Atrys Health SA
MAD:ATRY

Watchlist Manager

Atrys Health SA

MAD:ATRY

Watchlist

Dividends

Discount Rate

Price: 3.15 EUR -1.87% Market Closed

Market Cap: 239.2m EUR

Have any thoughts about
Atrys Health SA?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Fubotv Inc NYSE:FUBO	Media
US	Bank of America Corp NYSE:BAC	Banking
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Uber Technologies Inc NYSE:UBER	Road & Rail
CN	NIO Inc NYSE:NIO	Automobiles
US	Fluor Corp NYSE:FLR	Construction
US	Jacobs Engineering Group Inc NYSE:J	Professional Services
US	TopBuild Corp NYSE:BLD	Consumer products
US	Abbott Laboratories NYSE:ABT	Health Care
US	Chevron Corp NYSE:CVX	Energy
US	Occidental Petroleum Corp NYSE:OXY	Energy
US	Matrix Service Co NASDAQ:MTRX	Construction
US	Automatic Data Processing Inc NASDAQ:ADP	Technology
US	Qualcomm Inc NASDAQ:QCOM	Semiconductors
US	PayPal Holdings Inc NASDAQ:PYPL	Technology
US	Ambarella Inc NASDAQ:AMBA	Semiconductors

Add Price Alert

Price Target:

Last Price: 3.15 EUR

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

ATRY Alert

Atrys Health SA

3.15

-0.06 (-1.87%)

52 Week Range	2.79 4.21
Price Target

We'll email you a reminder when the closing price reaches EUR.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Fubotv Inc NYSE:FUBO	US
	Bank of America Corp NYSE:BAC	US
	Palantir Technologies Inc NYSE:PLTR	US
	Uber Technologies Inc NYSE:UBER	US
	NIO Inc NYSE:NIO	CN
	Fluor Corp NYSE:FLR	US
	Jacobs Engineering Group Inc NYSE:J	US
	TopBuild Corp NYSE:BLD	US
	Abbott Laboratories NYSE:ABT	US
	Chevron Corp NYSE:CVX	US
	Occidental Petroleum Corp NYSE:OXY	US
	Matrix Service Co NASDAQ:MTRX	US
	Automatic Data Processing Inc NASDAQ:ADP	US
	Qualcomm Inc NASDAQ:QCOM	US
	PayPal Holdings Inc NASDAQ:PYPL	US
	Ambarella Inc NASDAQ:AMBA	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Atrys Health SA

What unique competitive advantages
does Atrys Health SA hold over its rivals?

What risks and challenges
does Atrys Health SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Atrys Health SA.

What unique competitive advantages
does Atrys Health SA hold over its rivals?

What risks and challenges
does Atrys Health SA face in the near future?

Has there been any significant insider trading activity
in Atrys Health SA recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Atrys Health SA.

Provide P/S
for Atrys Health SA.

Provide P/E
for Atrys Health SA.

Provide P/OCF
for Atrys Health SA.

Provide P/FCFE
for Atrys Health SA.

Provide P/B
for Atrys Health SA.

Provide EV/S
for Atrys Health SA.

Provide EV/GP
for Atrys Health SA.

Provide EV/EBITDA
for Atrys Health SA.

Provide EV/EBIT
for Atrys Health SA.

Provide EV/OCF
for Atrys Health SA.

Provide EV/FCFF
for Atrys Health SA.

Provide EV/IC
for Atrys Health SA.

Show me price targets
for Atrys Health SA made by professional analysts.

What are the Revenue projections
for Atrys Health SA?

How accurate were the past Revenue estimates
for Atrys Health SA?

What are the Net Income projections
for Atrys Health SA?

How accurate were the past Net Income estimates
for Atrys Health SA?

What are the EPS projections
for Atrys Health SA?

How accurate were the past EPS estimates
for Atrys Health SA?

What are the EBIT projections
for Atrys Health SA?

How accurate were the past EBIT estimates
for Atrys Health SA?

Compare the revenue forecasts
for Atrys Health SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Atrys Health SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Atrys Health SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Atrys Health SA compared to its peers.

Compare the P/E ratios
of Atrys Health SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Atrys Health SA with its peers.

Analyze the financial leverage
of Atrys Health SA compared to its main competitors.

Show all profitability ratios
for Atrys Health SA.

Provide ROE
for Atrys Health SA.

Provide ROA
for Atrys Health SA.

Provide ROIC
for Atrys Health SA.

Provide ROCE
for Atrys Health SA.

Provide Gross Margin
for Atrys Health SA.

Provide Operating Margin
for Atrys Health SA.

Provide Net Margin
for Atrys Health SA.

Provide FCF Margin
for Atrys Health SA.

Show all solvency ratios
for Atrys Health SA.

Provide D/E Ratio
for Atrys Health SA.

Provide D/A Ratio
for Atrys Health SA.

Provide Interest Coverage Ratio
for Atrys Health SA.

Provide Altman Z-Score Ratio
for Atrys Health SA.

Provide Quick Ratio
for Atrys Health SA.

Provide Current Ratio
for Atrys Health SA.

Provide Cash Ratio
for Atrys Health SA.

What is the historical Revenue growth
over the last 5 years for Atrys Health SA?

What is the historical Net Income growth
over the last 5 years for Atrys Health SA?

What is the current Free Cash Flow
of Atrys Health SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Atrys Health SA.

EV/EBITDA
Enterprise Value to EBITDA

13.1

Current

27.2

Median

12.6

Industry

Lower than median

Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA

13.1

Enterprise Value

413.6m EUR

EBITDA

31.6m EUR

All Countries

Forward Multiples

			Market Cap	EV/EBITDA
ES	A	Atrys Health SA MAD:ATRY	239.2m EUR	13.1
US		Cigna Corp NYSE:CI	88B USD	8.8
US	C	Cigna Group XMUN:CGN	80.2B EUR	8.8
US		CVS Health Corp NYSE:CVS	70.9B USD	9.1
DE		Fresenius Medical Care AG XMUN:FME	21B EUR	9.6
DE		Fresenius SE & Co KGaA XETRA:FRE	18.9B EUR	14.6
US		Laboratory Corporation of America Holdings NYSE:LH	19.1B USD	13.1
US		Quest Diagnostics Inc NYSE:DGX	17.3B USD	12.4
MY	H	Hong Seng Consolidated Bhd KLSE:HONGSENG	58.5B MYR	-755.1
US		DaVita Inc NYSE:DVA	11.9B USD	7.7
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	10.5B EUR	6.3

				EBITDA Growth
ES	A	Atrys Health SA MAD:ATRY	Average EV/EBITDA: 10.4 13.1	73%
US		Cigna Corp NYSE:CI	8.8	28%
US	C	Cigna Group XMUN:CGN	8.8	28%
US		CVS Health Corp NYSE:CVS	9.1	28%
DE		Fresenius Medical Care AG XMUN:FME	9.6	28%
DE		Fresenius SE & Co KGaA XETRA:FRE	14.6	62%
US		Laboratory Corporation of America Holdings NYSE:LH	13.1	53%
US		Quest Diagnostics Inc NYSE:DGX	12.4	28%
MY	H	Hong Seng Consolidated Bhd KLSE:HONGSENG	Negative Multiple: -755.1	N/A
US		DaVita Inc NYSE:DVA	7.7	22%
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	6.3	28%

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

EV/EBITDA

9.3

2-Years Forward

EV/EBITDA

8.2

3-Years Forward

EV/EBITDA

7.4

Atrys Health SA
MAD:ATRY

EV/EBITDA
Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

Atrys Health SA MAD:ATRY

EV/EBITDA Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

Atrys Health SA
MAD:ATRY

EV/EBITDA
Enterprise Value to EBITDA